tmem41b Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to TMEM41B Antibody

TMEM41B (Transmembrane Protein 41B) antibodies are biological tools designed to detect and study the expression, localization, and functional roles of the TMEM41B protein. This endoplasmic reticulum (ER)-resident protein regulates autophagy, lipid mobilization, and viral replication. Antibodies targeting TMEM41B enable researchers to investigate its involvement in cellular processes such as lipid droplet dynamics, autophagosome formation, and host-pathogen interactions .

Viral Replication Studies

  • Coronaviruses and Flaviviruses: TMEM41B antibodies confirmed its role as a critical host factor for SARS-CoV-2, HCoV-229E, Zika virus (ZIKV), and dengue virus (DENV). Knockout studies using TMEM41B-specific shRNAs reduced viral replication by >80% .

  • Mechanistic Insights: Antibodies helped demonstrate TMEM41B’s involvement in forming viral replication organelles (e.g., double-membrane vesicles for coronaviruses) and regulating lipid-dependent clathrin-coated pit dynamics during viral entry .

Autophagy and Lipid Metabolism

  • Lipid Droplet Dynamics: TMEM41B antibodies identified enlarged lipid droplets in TMEM41B-deficient cells, linking the protein to fatty acid mobilization and β-oxidation .

  • ER Scramblase Activity: Studies using these antibodies revealed TMEM41B’s role as a phospholipid scramblase, essential for maintaining lipid bilayer homeostasis .

Immune Regulation

  • Interferon-Stimulated Gene (ISG): TMEM41B antibodies verified its induction by interferon-γ, highlighting its dual role as a proviral factor and immune modulator .

Validation and Specificity

  • Knockout Validation: Commercially available antibodies (e.g., Cell Signaling #68071) showed no cross-reactivity in TMEM41B-knockout cell lines, confirming specificity .

  • siRNA Knockdown: Abcam’s ab314763 demonstrated reduced signal intensity in siRNA-treated 293T cells, correlating with TMEM41B mRNA depletion .

  • Cross-Species Reactivity: Proteintech’s 29270-1-AP detects TMEM41B in human and mouse tissues, enabling comparative studies .

Challenges and Limitations

  • Isoform Diversity: TMEM41B has four splicing variants, but only isoform 1 (full-length VTT domain) supports viral replication. Commercial antibodies may not distinguish all isoforms .

  • Background Staining: Some antibodies (e.g., Sigma-Aldrich HPA014946) exhibit nonspecific signals in immunohistochemistry, requiring optimization .

Future Directions

TMEM41B antibodies are pivotal for developing therapeutics targeting viral replication organelles and lipid metabolism. Ongoing research focuses on:

  • Broad-Spectrum Antivirals: Blocking TMEM41B’s scramblase activity to inhibit SARS-CoV-2, DENV, and PRV .

  • Metabolic Disorders: Investigating TMEM41B’s role in obesity and lipid storage diseases using knockout models .

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
tmem41b; zgc:158275; Transmembrane protein 41B; Protein stasimon
Target Names
tmem41b
Uniprot No.

Target Background

Function
Tmem41b is a phospholipid scramblase that plays a crucial role in lipid homeostasis and membrane dynamics. It exhibits phospholipid scramblase activity towards various lipids, including cholesterol, phosphatidylserine, phosphatidylethanolamine, and phosphatidylcholine. This activity is essential for the formation of autophagosomes, specifically during the early stages of biogenesis at the endoplasmic reticulum (ER) membrane. By redistributing lipids between the leaflets of the ER membrane, Tmem41b facilitates the extraction of lipids by Atg2 (Atg2a or Atg2b), which is crucial for autophagosome assembly. Beyond autophagy, Tmem41b is involved in other processes requiring phospholipid scramblase activity. Notably, it is essential for the proper development of motor neurons.
Gene References Into Functions
  1. Restoring Stasimon expression in the motor circuit effectively corrects defects in neuromuscular junction transmission and muscle growth in Drosophila SMN mutants. Furthermore, it ameliorates aberrant motor neuron development in SMN-deficient zebrafish. PMID: 23063131
Database Links
Protein Families
TMEM41 family
Subcellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein. Endomembrane system.

Q&A

What is TMEM41B and why is it significant for research?

TMEM41B (transmembrane protein 41B), also known as Stasimon, is a six-transmembrane domain protein that localizes to the endoplasmic reticulum. It has emerged as a critical factor in multiple biological processes, including autophagosome biogenesis, lipid mobilization, and viral replication. TMEM41B has been identified as a major target of survival motor neuron (SMN)-dependent U12 splicing and is required for motor circuit function . Its calculated molecular weight is 32 kDa, though it is typically observed at 22-28 kDa in experimental conditions . The protein has gained significant research interest after being identified as a crucial host factor required for the replication of diverse coronaviruses, including SARS-CoV-2 . Studies of TMEM41B provide insights into fundamental cellular processes and potential therapeutic targets for viral infections.

What applications are validated for TMEM41B antibody?

The TMEM41B antibody (29270-1-AP) has been validated for multiple experimental applications, as demonstrated in published literature. The primary applications include:

ApplicationValidation StatusPublication Support
Western Blot (WB)Validated4 publications cited
Immunohistochemistry (IHC)Validated1 publication cited
Immunofluorescence (IF)Validated2 publications cited
ELISAValidatedNot specified in publications
Knockdown/Knockout VerificationValidated3 publications cited

What are the recommended dilutions for different applications?

Optimal dilution ranges have been established for different applications:

ApplicationRecommended Dilution
Western Blot (WB)1:1000-1:6000
Immunohistochemistry (IHC)1:50-1:500

It is important to note that the optimal dilution may be sample-dependent. Researchers are recommended to titrate the antibody in each testing system to obtain optimal results . For immunohistochemistry applications, antigen retrieval with TE buffer pH 9.0 is suggested, though citrate buffer pH 6.0 may also be used as an alternative .

What positive controls should be used for TMEM41B antibody validation?

For Western blot applications, A549 cells and HeLa cells have been confirmed as positive controls that express detectable levels of TMEM41B . For immunohistochemistry, mouse lung tissue, mouse testis tissue, and human lung tissue have been validated as positive controls . When establishing knockout validation controls, researchers should be aware that commercially available antibodies may show background staining in knockout lines, necessitating careful experimental design and interpretation .

How can I validate TMEM41B knockout or knockdown efficiency?

Validating TMEM41B knockout or knockdown requires a multi-faceted approach due to challenges with antibody specificity. Successful validation strategies include:

What methods are effective for studying TMEM41B localization?

Due to challenges with antibody specificity for endogenous TMEM41B, several approaches have proven effective for studying its subcellular localization:

  • Fluorescent protein tagging: Both N- and C-terminal fusions of eGFP to TMEM41B have been successfully used to monitor localization. These constructs showed a reticular pattern characteristic of ER localization, with higher expression in the perinuclear region compared to the cell periphery . Functionality of these constructs can be verified by complementation assays in knockout cell lines .

  • Epitope tagging of endogenous loci: CRISPR-mediated knock-in of tags (e.g., Myc epitope) at the C-terminus of endogenous TMEM41B provides a more physiological approach to visualization. This method has confirmed robust co-localization with the ER marker calnexin .

  • Co-localization studies: When visualizing TMEM41B, co-staining with ER markers like calnexin or KDEL has shown high but not complete co-localization, helping to define its specific subdomain within the ER .

How can I assess TMEM41B's role in autophagy experimentally?

To investigate TMEM41B's role in autophagy, researchers have successfully employed several methodologies:

  • Monitoring autophagy markers: Analysis of autophagy cargo receptors (p62, NDP52) in TMEM41B-depleted cells under basal and activated autophagy conditions reveals defects in autophagosome biogenesis .

  • Autophagosome formation assays: Comparing the formation and maturation of autophagosomes in control versus TMEM41B knockout cells using markers such as LC3 can demonstrate TMEM41B's role in this process .

  • Genetic complementation: Reintroduction of wild-type TMEM41B into knockout cells to rescue autophagy defects confirms the specificity of the observed phenotypes .

  • Interaction proteomics: Immunoprecipitation of tagged TMEM41B followed by mass spectrometry has identified interactions with components of the COPI complex and other ER proteins, providing insights into its molecular mechanism .

What are the phenotypes of TMEM41B knockout cells related to lipid metabolism?

TMEM41B knockout cells display distinct lipid metabolism phenotypes that can be quantitatively assessed:

How does TMEM41B deficiency affect cellular metabolism?

TMEM41B knockout impacts cellular metabolism in several measurable ways:

  • Decreased mitochondrial respiration: TMEM41B-depleted cells display a small but significant decrease in basal mitochondrial oxygen consumption .

  • Increased glycolysis: Extracellular acidification rates are increased in TMEM41B knockout cells, suggesting that they may have increased glycolysis to compensate for defects in mitochondrial respiration .

  • Reduced β-oxidation: By measuring oxygen consumption in the presence or absence of etomoxir (an inhibitor of mitochondrial fatty acid import), studies have demonstrated that TMEM41B-deficient cells have significantly lower endogenous fatty acid utilization rates .

  • ER structure alterations: As an ER-resident protein, TMEM41B deficiency may alter ER morphology or function, which in turn affects lipid metabolism pathways .

What evidence supports TMEM41B as a host factor for coronavirus replication?

Multiple experimental approaches have established TMEM41B as a critical host factor for coronavirus replication:

  • Genome-wide screening: A genome-wide host-dependency factor screen with HCoV-229E identified TMEM41B as the highest magnitude hit with an unknown function during infection .

  • CRISPR validation: Targeted CRISPR-Cas9 knockout of TMEM41B provided protection from cytopathic effects during coronavirus infection and significantly reduced viral RNA levels .

  • RNAi confirmation: siRNA-mediated knockdown of TMEM41B in multiple cell types confirmed significant reduction in viral infection levels, demonstrating that the requirement for TMEM41B is not cell type specific .

  • Cross-species validation: The requirement for TMEM41B is conserved across coronaviruses from different genera, including HCoV-229E, SARS-CoV-2, and PDCoV, suggesting it as a potential broad-spectrum target .

At what stage of the viral life cycle does TMEM41B function?

Time-course experiments with knockout cell lines have provided insights into when TMEM41B functions during viral infection:

  • Early replication block: Despite similar or higher viral RNA levels at 1 hour post-infection (representing initial viral inoculum), viral replication was undetectable during the first 10 hours of infection in TMEM41B knockout cell lines .

  • Replication complex formation: TMEM41B is believed to be involved in the formation of ER-derived viral replication complexes, which are essential for coronavirus replication .

  • Lipid trafficking role: Research suggests that TMEM41B controls lipid trafficking, which is important for virally-induced replication complex formation rather than serving as a structural component of these complexes .

  • Distinct from viral entry: The experimental data indicates that TMEM41B is not required for viral genomic release from the endosome but rather functions at subsequent stages of replication .

What methodological approaches can assess TMEM41B's role in viral infection?

Several experimental approaches have proven effective for studying TMEM41B's function in viral infection:

  • Viral RNA quantification: RT-qPCR to measure viral RNA levels at different time points post-infection in control versus TMEM41B-depleted cells .

  • Viral titer determination: Quantifying infectious virus production through plaque assays or TCID50 assays .

  • Cytopathic effect monitoring: Assessing cell viability over infection time courses to determine if TMEM41B loss blocks initial infection or viral spread .

  • Confocal microscopy: Visualizing the relationship between TMEM41B and viral replication complexes using markers such as double-stranded RNA (dsRNA) .

  • Complementation studies: Reintroduction of TMEM41B into knockout cells to rescue viral replication, confirming the specificity of the observed phenotypes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.